Frontlight ResearchEarly access
Colorectal cancer trials in China
616 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePersonalized DC Vaccine for Postoperative Cancer
- Where
- Chengdu
- Age
- 18 years to 100 years
- People
- 80
- Run by
- Sichuan University
See details and how to joinNCT04147078 - Phase 2Taking peopleCryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis
- Where
- Shanghai
- Age
- 18 years and over
- People
- 25
- Run by
- Fudan University
See details and how to joinNCT05057052 - Phase 2Taking peopleIrinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 36
- Run by
- Fudan University
See details and how to joinNCT06763029 - No phaseEnrolling by invitationMulticenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer
- Where
- Changsha
- People
- 200
- Run by
- Yue Gou
See details and how to joinNCT06849362 - Phase 2Not yet taking people in ChinaA Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer
- Where
- Hanzhou
- Age
- 18 years to 75 years
- People
- 80
- Run by
- Tasly Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06838546 - No phaseNot yet taking people in ChinaRATME Vs LATME in Middle and Low Rectal Cancer
- Where
- Changchun
- Age
- 18 years to 75 years
- People
- 1,026
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT06105203 - Phase 2Taking peopleEfficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
- Where
- Jinhua
- Age
- 18 years to 75 years
- People
- 36
- Run by
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
See details and how to joinNCT06282445 - No phaseTaking peopleRegorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC
- Where
- Changzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- The First People's Hospital of Changzhou
See details and how to joinNCT06456515 - Phase 2Taking people"Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer"
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 52
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT06829355 - No phaseTaking peopleNanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue
- Where
- Shenyang
- Age
- 18 years to 75 years
- People
- 76
- Run by
- Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT06830018 - Phase 1Taking peopleARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 560
- Run by
- Hansoh BioMedical R&D Company
See details and how to joinNCT06825624 - Phase 1Taking peopleA Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal Cancer
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 260
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06717880 - Phase 1/2Taking peoplePhase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 188
- Run by
- Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT06819215 - Phase 2Taking peopleEvaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Affiliated Hospital of Nantong University
See details and how to joinNCT06643793 - No phaseTaking peopleThe Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)
- Where
- Shanghai
- Age
- 18 years and over
- People
- 30
- Run by
- Ruijin Hospital
See details and how to joinNCT06601075 - No phaseTaking peopleClinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 1,200
- Run by
- Sun Yat-sen University
See details and how to joinNCT06485609 - Phase 1/2Taking peopleSintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer
- Where
- Shenzhen
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
See details and how to joinNCT06776757 - Phase 2Taking peopleAdebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locally Advanced Rectal Cancer
- Where
- Jinan
- Age
- 18 years to 85 years
- People
- 31
- Run by
- Feng Tian
See details and how to joinNCT06765616 - Phase 3Taking peopleXian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer
- Where
- Nanjing
- Age
- 20 years to 80 years
- People
- 730
- Run by
- Jiangsu Famous Medical Technology Co., Ltd.
See details and how to joinNCT05709249 - No phaseTaking peopleNeoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
- Where
- Nanchang
- Age
- 18 years to 70 years
- People
- 10
- Run by
- The First Affiliated Hospital of Nanchang University
See details and how to joinNCT06751914 - No phaseTaking peopleNeoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
- Where
- Nanchang
- Age
- 18 years to 70 years
- People
- 10
- Run by
- The First Affiliated Hospital of Nanchang University
See details and how to joinNCT06751940 - No phaseTaking peopleNeoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
- Where
- Nanchang
- Age
- 18 years to 70 years
- People
- 10
- Run by
- The First Affiliated Hospital of Nanchang University
See details and how to joinNCT06751953 - No phaseTaking peopleNeoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
- Where
- Nanchang
- Age
- 18 years to 70 years
- People
- 10
- Run by
- The First Affiliated Hospital of Nanchang University
See details and how to joinNCT06751966 - Phase 4Taking peopleSurvival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer
- Where
- Beijing
- Age
- 18 years and over
- People
- 320
- Run by
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
See details and how to joinNCT05894694 - No phaseTaking peopleExploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
- Where
- Xi'an
- Age
- 18 years to 80 years
- People
- 100
- Run by
- Xijing Hospital
See details and how to joinNCT06613165